Angiotensin-(1-7) oral treatment after experimental myocardial infarction leads to downregulation of CXCR4.

Gómez-Mendoza, Diana Paola

Angiotensin-(1-7) oral treatment after experimental myocardial infarction leads to downregulation of CXCR4. [electronic resource] - Journal of proteomics 09 2019 - 103486 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1876-7737

10.1016/j.jprot.2019.103486 doi


Administration, Oral
Angiotensin I--pharmacology
Animals
Down-Regulation--drug effects
Male
Mitochondria, Heart--metabolism
Myocardial Infarction--metabolism
Myocardium--metabolism
Peptide Fragments--pharmacology
Proteome--metabolism
Proteomics
Rats
Rats, Wistar
Receptors, CXCR4--biosynthesis